Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. [Phase 2]
Phase 2 study results evaluating the combination of ipilimumab and nivolumab in patients with anti-PD-1 therapy–resistant advanced non-small…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Universal Cancer Peptide-based Vaccination in Metastatic NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial of a universal cancer peptide-based vaccination for metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC [NA]
Completion of a clinical trial evaluating the NCCN decision support tool for patients with non-small cell lung cancer; results were posted o…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: QYJD Compound Preparation Promotes Rapid Postoperative Recovery in Early-stage NSCLC Patients by Regulating Tissue Microecology: a Prospective, Randomized Controlled, Open-label, Phase I Clinical Study With Predefined Future Exploration [Phase 1]
A Phase 1 randomized, open-label trial evaluating QYJD Compound Preparation for improving postoperative recovery in early-stage non-small ce…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs [NA]
Clinical trial update indicates Ivonescimab (AK112) combined with chemotherapy for leptomeningeal metastasis in non-small cell lung cancer a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of DSP107 alone and in combination with atezolizumab. The study targets patients with a…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma [Phase 2]
This Phase 2 trial update reports the completion of a study evaluating atezolizumab, bevacizumab, and chemotherapy in EGFR-mutant stage IIIB…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS [Phase 1, Phase 2]
This Clinical Trials update describes a Phase 1/Phase 2 trial evaluating intratumoral injection of IP-001 following thermal ablation in pati…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 study evaluating durvalumab given with chemoradiation in patients with unresectable non-small cell lung cancer. Results were posted …
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC
This clinical study investigates molecular residual disease, dynamic monitoring, and recurrence in Stage III driver-mutated non-small cell l…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy [Phase 1]
Phase 1 clinical trial update for QL-1706 antibodies combined with pulsed low dose rate external irradiation (PLDR) in patients with cancers…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Clinical trial update for OR502, a monoclonal antibody targeting LILRB2, studied alone and with anticancer agents in Phase 1/2; recruitment …
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC [Phase 2]
A Phase 2 trial comparing radical surgical resection with ablative stereotactic radiotherapy for operable stage I non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation [Phase 1]
Phase 1 study evaluating ABN401 for safety, pharmacokinetics, pharmacodynamics, and antitumor activity in advanced solid tumors and non-smal…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: FHND9041 Versus Afatinib for Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing FHND9041 to Afatinib for non-small cell lung cancer is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating befotertinib plus bevacizumab or platinum-based chemotherapy for resectable locally-advanced EGFR-mutan…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER [NA]
This document describes the PRIMER study on the feasibility of primer-shot radiotherapy for non-small cell lung cancer, currently in recruit…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for HB0036 in adults with advanced solid tumors, including non-small cell lung cancer, focusing on safety …
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions [NA]
A clinical trial comparing cryobiopsy to forceps biopsy for peripheral pulmonary lesions in non-small cell lung cancer patients, currently e…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude Areas
This document reports a clinical trial investigating the efficacy of immunotherapy and the occurrence and severity of adverse reactions in p…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: 68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
This clinical trial evaluates the radiotracer 68Ga-grazytracer PET/CT for early assessment of response to neoadjuvant immunotherapy in resec…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy [Phase 2]
A Phase 2 study evaluating sargramostim plus pembrolizumab with or without pemetrexed in advanced non-small cell lung cancer after chemoimmu…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6) [Phase 2]
Phase 2 trial of Sunvozertinib (DZD9008) in pretreated non-small cell lung cancer patients with EGFR Exon 20 insertion; the study Wu-Kong6 i…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation [Phase 2]
A Phase 2 trial of TY-9591 in non-small cell lung cancer with EGFR activating mutation and brain or leptomeningeal metastases has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating how itraconazole or rifampicin affect TY-9591 tablets in healthy subjects.